Current influencing factors for prostate cancer ICPI include TMB, microsatellite instability/mismatch repair (MSI/MMR), and cyclin-dependent kinase 12 gene, but more biomarkers affecting ICPI are still being studied and explored. This evidence concerns the gene CDK12 and Familial prostate cancer.